Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis

Affiliations

• ¹ German Center for Health Services Research in Dermatology, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
• ² Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Campus Kiel, Germany.
• ³ Clinic and Polyclinic for Dermatology and Allergology, University Hospital Bonn, Bonn, Germany.
• ⁴ Eli Lilly and Company, Indianapolis, Indiana, USA.
• ⁵ Department of Dermatology, Medical University of Vienna, Vienna, Austria.
• ⁶ HaaPACS GmbH, Schriesheim, Germany.
• ⁷ Center for Innovative Diagnostics and Therapy Rheumatology/Immunology (CIRI) of the University of Frankfurt, Frankfurt am Main, Germany.
• ⁸ Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, Germany.